What is the recommended treatment for Chlamydia (Chlamydia trachomatis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chlamydia Treatment Recommendations

For uncomplicated chlamydial infections in non-pregnant adults, doxycycline 100 mg orally twice daily for 7 days is the first-line treatment due to its superior efficacy (95.5% for urogenital infections and 96.9% for rectal infections). 1

First-Line Treatment Options

  • Doxycycline: 100 mg orally twice daily for 7 days

    • Highest efficacy for both urogenital (95.5%) and rectal infections (96.9%)
    • Requires 7-day adherence to treatment regimen 1
  • Azithromycin: 1 g orally in a single dose

    • Slightly lower efficacy (92% for urogenital infections, 76.4% for rectal infections)
    • Preferred when adherence is a concern - allows for directly observed therapy 1
    • Single-dose therapy eliminates compliance issues 2, 3

Special Populations

Pregnant Women

Doxycycline and azithromycin are contraindicated during pregnancy. The recommended regimens are:

  • First choice: Erythromycin base 500 mg orally four times daily for 7 days 1, 4
  • Alternative options if first choice is not tolerated:
    • Erythromycin base 250 mg orally four times daily for 14 days
    • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
    • Erythromycin ethylsuccinate 400 mg orally four times daily for 14 days
    • Amoxicillin 500 mg orally three times daily for 7-10 days 5, 1

Adolescents

  • Same regimens as adults, except ofloxacin is not recommended for those ≤17 years 5
  • Single-dose azithromycin may be particularly beneficial for improving adherence 6

Partner Management

  • All sexual partners from the preceding 60 days should be evaluated, tested, and treated 1
  • The most recent partner should be treated even if the last sexual contact was more than 60 days before diagnosis 1
  • Patients and partners should abstain from sexual intercourse until:
    • 7 days after single-dose therapy, or
    • Until completion of a 7-day regimen 1

Follow-Up Recommendations

  • Test of cure is generally not needed after completing treatment with doxycycline or azithromycin unless symptoms persist 1
  • Consider test of cure 3 weeks after completion of treatment with erythromycin 1
  • Retesting approximately 3 months after treatment is recommended due to high risk of reinfection 1

Clinical Considerations

Efficacy Comparison

Medication Urogenital Infection Rectal Infection Advantages Disadvantages
Doxycycline 95.5% 96.9% Higher efficacy 7-day course
Azithromycin 92% 76.4% Single-dose Lower efficacy for rectal infections

Common Pitfalls and Caveats

  1. Co-infection with gonorrhea: Consider dual therapy with ceftriaxone 125 mg IM in a single dose PLUS azithromycin or doxycycline due to increasing resistance patterns 1

  2. Medication adherence: For patients with adherence concerns, directly observed therapy with single-dose azithromycin is preferable over multi-day regimens 1, 2

  3. Untreated complications: Failure to treat can lead to serious sequelae, particularly in women, including:

    • Pelvic inflammatory disease (PID)
    • Ectopic pregnancy
    • Infertility
    • Chronic pelvic pain 1, 7
  4. Reinfection risk: High rates of reinfection (up to 39% in some studies) necessitate partner treatment and follow-up testing 5, 1

  5. Optimal administration: Erythromycin tablets are best absorbed when taken in the fasting state (at least 30 minutes and preferably 2 hours before meals) 4

By following these evidence-based treatment recommendations, clinicians can effectively manage chlamydial infections while minimizing complications and preventing transmission.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.